Skip to content

The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer

The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer: A Multicenter Randomized Controlled Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07338643
Enrollment
1200
Registered
2026-01-14
Start date
2026-02-26
Completion date
2028-08-01
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Pain, Black Stools, Constipation, Diarrhea

Brief summary

The investigators conducted a multicenter randomized controlled trial to explore the adjuvant effect of artificial intelligence in the detection of precancerous lesions in the proximal colon.This is a prospective, multicenter, single-blind, parallel randomized controlled trial.During the colonoscopy retraction process, the investigators aimed to compare the detection rates of proximal colon adenomas with and without the assistance of an AI(Artificial Intelligence) diagnostic device.

Interventions

PROCEDUREAI group

Full AI assistance was used throughout the standard colonoscopy procedure.

PROCEDURESerial group

After normal withdrawal of the colonoscope to the splenic flexure during standard colonoscopy, full AI assistance was initiated. The colonoscope was re-entered to the ileocecal region for observation. Any missed lesions were recorded.

PROCEDUREStandard colonoscopy group

The standard colonoscopy procedure was performed as usual

Sponsors

Limian Er
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1.Patients with symptoms such as abdominal pain, black stools, constipation, or diarrhea undergo colonoscopy for diagnostic purposes.

Exclusion criteria

1. Those with inflammatory bowel disease, colorectal cancer and surgical history, as well as those with familial polyposis syndrome 2. Those with intestinal obstruction or malignant tumors 3. Patients with colorectal lesions that need to be treated in stages. 4. Other contraindications for colonoscopy examination.

Design outcomes

Primary

MeasureTime frameDescription
Average adenoma detection rateDay 1The result is the number of adenomas detected by colonoscopy divided by the total number of colonoscopies performed.
Adenoma detection rateDay 1The proportion of patients who have at least one adenoma detected during colonoscopy examination

Countries

China

Contacts

Primary ContactLi mian Er, doctor
Hbsyelm@163.com13513379068
Backup ContactZhenzhen Wang, master
13803365602@163.com13803365602

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026